Bo Liang

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Topics

Regulatory T Cells

Ejection Fraction

Cardiovascular Disease

Top Venues

Cardiovascular diabetology

Disease markers

BMC complementary medicine and therapies

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Zhi Zhao, Yi Liang, Ting Yin, Hui-Ling Liao, Bo Liang
Identification of Potential Crucial Biomarkers in STEMI Through Integrated Bioinformatic Analysis. Arquivos brasileiros de cardiologia 121 (2) (2024)
Qi-Gang Lan, Yi Liang, Liang Liu, Hai-Lun Xie, Rui Wang, Jing-Hong Zhao, Bo Liang
Causal relationships between vitamin E and multiple kidney diseases: evidence from trans-ethnic Mendelian randomization study. European journal of nutrition (2024)
Li-Zhi Zhao, Yi Liang, Ting Yin, Hui-Ling Liao, Bo Liang
Identification of Potential Crucial Biomarkers in STEMI Through Integrated Bioinformatic Analysis. Arquivos brasileiros de cardiologia 121 (2) (2024)
Jun-Zhang Chen, Bo Liang
Comparison of American and European guidelines for cardio-oncology of heart failure. Heart failure reviews (2023)
Jun-Zhang Chen, Bo Liang
Letter by Chen and Liang Regarding Article, "Impact of Diabetes on Myocardial Fibrosis in Patients With Hypertension: The REMODEL Study". Circulation. Cardiovascular imaging (2023)
Bo Liang, Wei-Lin Liang, Hui-Ling Liao
Single-cell and bulk characterisation of the distinct immune landscape and possible regulatory mechanisms in coronary plaques vulnerability. Clinical and translational medicine 13 (6) (2023)
Wei-Lin Liang, Bo Liang
Soluble Guanylate Cyclase Activators and Stimulators in Patients with Heart Failure. Current cardiology reports (2023)
Jun-Zhang Chen, Bo Liang
Cell Therapies in Diabetic Kidney Disease: Is It Time for Clinical Translation? Journal of the American Society of Nephrology : JASN 34 (12) (2023)
Bo Liang, Ning Gu
High-speed rotational atherectomy in coronary artery calcification: The randomized ROTAXUS and PREPARE-CALC trials. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 100 (1) (2022)
Bo Liang, Yi Liang, Li-Zhi Zhao, Yu-Xiu Zhao, Ning Gu
Rivaroxaban for cancer-associated venous thromboembolism. Science progress 104 (2) (2022)
Bo Liang, Yi Liang, Ning Gu
Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction. BMC cardiovascular disorders 22 (1) (2022)
Bo Liang, Yong-Chun Zhu, Jia Lu, Ning Gu
Effects of Traditional Chinese Medication-Based Bioactive Compounds on Cellular and Molecular Mechanisms of Oxidative Stress. Oxidative medicine and cellular longevity 2021 (2021)
Yi Liang, Bo Liang, Xin-Rui Wu, Wen Chen, Li-Zhi Zhao
Network Pharmacology-Based Systematic Analysis of Molecular Mechanisms of Dingji Fumai Decoction for Ventricular Arrhythmia. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Bo Liang, Ning Gu
Treatment strategies in patients with diabetes and three-vessel coronary disease: What should we choose? Cardiovascular diabetology 20 (1) (2021)
Xiaoxiao Zhang, Changle Shao, Songyi Cheng, Yao Zhu, Bo Liang, Ning Gu
Effect of Guanxin V in animal model of acute myocardial infarction. BMC complementary medicine and therapies 21 (1) (2021)
Bo Liang, Yi Liang, Rui Li, Ning Gu
Effect of renal denervation on long-term outcomes in patients with resistant hypertension. Cardiovascular diabetology 20 (1) (2021)
Jian-Guo Zhou, Bo Liang, Jian-Guo Liu, Su-Han Jin, Si-Si He, Benjamin Frey, Ning Gu, Sandra Rutzner, Markus Hecht, Hu Ma, Udo S Gaipl
Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy. Cells 10 (5) (2021)
Rong-Hua Yang, Bo Liang, Jie-Hua Li, Xiao-Bing Pi, Kai Yu, Shi-Jian Xiang, Ning Gu, Xiao-Dong Chen, Si-Tong Zhou
Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma. Journal of cellular and molecular medicine 25 (23) (2021)
Xin He, Bo Liang, Ning Gu
Th17/Treg Imbalance and Atherosclerosis. Disease markers 2020 (2020)
Bo Liang, Yu-Xiu Zhao, Ning Gu
Renal Denervation for Resistant Hypertension: Where Do We Stand? Current hypertension reports 22 (10) (2020)
Bo Liang, Xin He, Yu-Xiu Zhao, Xiao-Xiao Zhang, Ning Gu
Advances in Exosomes Derived from Different Cell Sources and Cardiovascular Diseases. BioMed research international 2020 (2020)
Bo Liang, Xiao-Xiao Zhang, Ning Gu
Virtual screening and network pharmacology-based synergistic mechanism identification of multiple components contained in Guanxin V against coronary artery disease. BMC complementary medicine and therapies 20 (1) (2020)
Bo Liang, Yan Zhou, Ling Fu, Hui-Ling Liao
Antiarrhythmic Mechanisms of Chinese Herbal Medicine Dingji Fumai Decoction. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)
Bo Liang, Shuang-Yang Li, Hui-Zhi Gong, Ling-Xue Wang, Jia Lu, Yu-Xiu Zhao, Ning Gu
Clinicopathological and Prognostic Roles of STAT3 and Its Phosphorylation in Glioma. Disease markers 2020 (2020)
Bo Liang, Ning Gu
Liraglutide in the treatment of heart failure: insight from FIGHT and LIVE. Cardiovascular diabetology 19 (1) (2020)
Bo Liang, Yu-Xiu Zhao, Ning Gu
Empagliflozin improves cardiac function in heart failure with reduced ejection fraction independent of loading conditions. Cardiovascular diabetology 19 (1) (2020)
Bo Liang, Fei-Hu Zou, Ling Fu, Hui-Ling Liao
Chinese Herbal Medicine Dingji Fumai Decoction for Ventricular Premature Contraction: A Real-World Trial. BioMed research international 2020 (2020)